+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients



Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients



Transplantation Proceedings 28(3): 1354-1355




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032190774

Download citation: RISBibTeXText

PMID: 8658691


Related references

Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients. Transplantation Proceedings 29(7): 2955-2957, 1997

Long-term outcome of the use of OKT3 to treat steroid-resistant acute renal allograft rejection. Transplant International 7(4): 278-283, 1994

Predicting Factors of Long-Term Results of Okt3 Therapy for Steroid Resistant Acute Rejection following Cadaveric Renal Transplantation. American Journal of Nephrology 19(6): 634-640, 1999

Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation. Transplantation Proceedings 30(4): 1170-1172, 1998

Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation. American Journal of Nephrology 19(6): 634-640, 1999

The effect of induction alg malg on the outcome of steroid resistant rejection treatment with okt3 in renal transplant patients. Transplantation Proceedings 23(1 BOOK 2): 1039-1040, 1991

The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients. Transplantation Proceedings 23(1 Pt 2): 1039-1040, 1991

Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection. Transplantation Proceedings 27(1): 1014-1015, 1995

Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center. Transplantation Proceedings 31(7): 2870-2871, 1999

Effect of OKT3 in steroid-resistant renal transplant rejection. Transplantation 59(3): 347-352, 1995

Severe thrombocytopenia with OKT3 use for steroid-resistant rejection in a cadaveric renal transplant recipient. Nephrology Dialysis Transplantation 11(11): 2378, 1996

OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection. Nephron. Clinical Practice 103(3): C94, 2006

OKT3 for the treatment of steroid-resistant acute renal allograft rejection. Nephron 77(3): 298-303, 1997

FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Transplantation Proceedings 28(6): 3166-3168, 1996

FK 506 is as effective as OKT3 for initial treatment for steroid resistant rejection in liver transplant patients. Hepatology 22(4 Part 2): 143A, 1995